Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "NIL"

323 News Found

E-learning in diabetes management for nurses launched
Public Health | April 19, 2022

E-learning in diabetes management for nurses launched

India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses


Lupin completes acquisition of brands from Anglo-French
Biotech | April 07, 2022

Lupin completes acquisition of brands from Anglo-French

The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products


All India Institute of Ayurveda signs MoU with Safdarjung hospital
News | April 07, 2022

All India Institute of Ayurveda signs MoU with Safdarjung hospital

The MoU sets down the guidelines for the establishment of an integrative medicine unit, joint research and academic activities in various fields of interest in Ayurveda and modern medicine


Vipergen’s DNA based drug discovery partnership with Theseus Pharma
Biotech | April 05, 2022

Vipergen’s DNA based drug discovery partnership with Theseus Pharma

Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target


Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President
News | April 01, 2022

Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President

Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India


Arzeda closes US$33 million Series B funding
Digitisation | April 01, 2022

Arzeda closes US$33 million Series B funding

Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology


Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
News | March 28, 2022

Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr

Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments


Seven ways the pharma industry can benefit from tech-driven logistics solutions
Opinion | March 24, 2022

Seven ways the pharma industry can benefit from tech-driven logistics solutions

The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable


IHL launches first zero assistance integrated health centre
Public Health | March 23, 2022

IHL launches first zero assistance integrated health centre

The first-of-its-kind unique centre will increase access to preventive & primary care


NIBIOHN identifies tissue-specific exosome marker candidates from blood
Biotech | March 22, 2022

NIBIOHN identifies tissue-specific exosome marker candidates from blood

Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease